Editorial: Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?

Nuclear Medicine Communications

Volumn 31, Issue 2, 2010, Pages 91-93

  Vyas, Nora S ^a   Patel, Neva H ^b   Nijran, Kuldip S ^b   Al Nahhas, Adil ^b   Puri, Basant K ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; CARBON 11; FALLYPRIDE F 18; FLUORODEOXYGLUCOSE F 18; TRACER; UNCLASSIFIED DRUG; WATER O 15;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOPAMINE METABOLISM; EDITORIAL; HUMAN; NEUROBIOLOGY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRESYNAPTIC MEMBRANE; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; METABOLISM; METHODOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING;

HUMANS; NEUROBIOLOGY; POSITRON-EMISSION TOMOGRAPHY; SCHIZOPHRENIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 75149129129     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283341830     Document Type: Editorial

References (20)

1. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 2000; 97:8104-8109.
2. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A 2001; 98:11650-11655.
3. Kyriakopoulos M, Vyas NS, Barker GJ, Chitnis XA, Frangou S. A diffusion tensor imaging study of white matter in early-onset schizophrenia. Biol Psychiatry 2008; 63:519-523.
4. Verhoeff NP. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders. Psychopharmacology (Berl) 1999; 147:217-249.
5. Wiser AK, Andreasen NC, O'Leary DS,Watkins GL, Boles PLL, Hichwa RD. Dysfunctional cortico-cerebellar circuits cause 'cognitive dysmetria' in schizophrenia. Neuroreport 1998; 9:1895-1899.
6. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS, Watkins GL, Boles PLL, et al. Recalling word lists reveals 'cognitive dysmetria' in schizophrenia: a positron emission tomography study. Am J Psychiatry 1999; 156:386-392.
7. Mukherjhee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, et al. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 2002; 46:170-188.
8. Kumakura Y, Cumming P, Vernaleken I, Buchholz H-G, Siessmeier T, Heinz A, et al. Elevated (18F) fluorodopamine turnover in brain of patients with schizophrenia: an (18F) fluorodopa/positron emission tomography study. J Neurosci 2007; 27:8080-8087.
9. McGowan S, Lawrence AD, Sales T, Quested D, Grasby P. Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic (18F) fluorodopa study. Arch Gen Psychiatry 2004; 61:134-142.
10. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 2009; 66:13-20.
11. Vyas NS, Hadjulis M, Vourdas A, Byrne P, Frangou S. The Maudsley early onset schizophrenia study: predictors of psychosocial outcome at 4-year follow-up. Eur Child Adolesc Psychiatry 2007; 16:465-470.
12. Christian BT, Lehrer DS, Shi B, Narayanan TK, Strohmeyer PS, Buchsbaum MS, et al. Measuring dopamine neuromodulation in the thalamus: using (F-18) fallypride PET to study dopamine release during a spatial attention task. Neuroimage 2006; 31:139-152.
13. MacDonald SW, Cervenka S, Farde L, Nyberg L, Bäckman L. Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia 2009; 47:2299-2304.
14. Nagano-Saito A, Kato T, Arahata Y, Washimi Y, Nakamura A, Abe Y, et al. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage 2004; 22:553-561.
15. Andreasen NC, Rezai K, Alliger R, Swayze VW II, Flaum M, Kirchner P, et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon-133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992; 49:943-958.
16. Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002; 5:267-271.
17. Ho BC, Wassink TH, O'Leary DS, Sheffield VC, Andreasen NC. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 2005; 10:287-298.
18. Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, Fischman AJ, et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1998; 1:318-323.
19. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosc 2002; 22:3708-3719.
20. Vernaleken I, Buchholz HG, Kumakura Y, Siessmeier T, Stoeter P, Bartenstein P, et al. Prefrontal cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory (18F)-fluoro- L-DOPA-PET investigation. Hum Brain Mapp 2007; 28:931-939.